The UK’s Food Safety Agency (FSA) recently imposed a maximum daily intake limit of 10mg for Cannabidiol (CBD) products. This decision has sparked concerns among consumers and industry experts regarding potential long-term liver or thyroid issues associated with CBD usage.
CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant popularity in recent years due to its potential health benefits. It is commonly used to alleviate pain, reduce anxiety, and improve sleep quality. However, as the CBD market continues to grow, regulators are becoming increasingly concerned about its safety and potential side effects.
The FSA’s decision to impose a maximum daily intake limit of 10mg is based on the advice of the government’s Committee on Toxicity (COT). The COT conducted a thorough review of available scientific evidence and concluded that consuming more than 10mg of CBD per day could pose potential risks to consumers’ health.
One of the main concerns raised by the COT is the potential long-term impact of CBD on liver function. Studies conducted on animals have shown that high doses of CBD can cause liver damage. While these studies were conducted using much higher doses than what is typically consumed by humans, the FSA and COT believe it is essential to exercise caution and set a maximum intake limit to protect public health.
Another concern highlighted by the COT is the potential impact of CBD on thyroid function. Some studies have suggested that CBD may interfere with the production of thyroid hormones, which play a crucial role in regulating metabolism, growth, and development. However, more research is needed to fully understand the extent of this interaction and its implications for human health.
It is important to note that the FSA’s maximum daily intake limit of 10mg applies specifically to CBD supplements and food products, not to prescribed medications or over-the-counter medicines containing CBD. These products are regulated differently and are subject to separate guidelines and restrictions.
The FSA’s decision has received mixed reactions from consumers and industry stakeholders. While some argue that the limit is overly cautious and restricts access to a potentially beneficial compound, others believe it is a necessary step to ensure consumer safety.
To address these concerns, the FSA has also called for the submission of novel food authorization applications for CBD products. This process will allow manufacturers to demonstrate the safety and quality of their products, ensuring that they meet the necessary standards before being sold to consumers.
In conclusion, the UK’s Food Safety Agency’s decision to impose a maximum daily intake limit of 10mg for CBD products aims to protect consumers from potential long-term liver or thyroid concerns associated with CBD usage. While the decision has sparked debates within the industry, it underscores the importance of ensuring the safety and quality of CBD products. As research on CBD continues to evolve, it is crucial for regulators, manufacturers, and consumers to stay informed and make informed decisions regarding CBD usage.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: Plato Data Intelligence.
- Source Link: https://zephyrnet.com/uks-food-safety-agency-limits-cbd-intake-from-food-or-drink-to-10mg-per-day-max-long-term-liver-or-thyroid-issues-looming/